Barclays’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-424,121
| Closed | -$1.7M | – | 6718 |
|
|
2019
Q4 | $1.7M | Buy |
424,121
+366,103
| +631% | +$1.72M | ﹤0.01% | 3176 |
|
|
2019
Q3 | $284K | Sell |
58,018
-8,682
| -13% | -$48.6K | ﹤0.01% | 4707 |
|
|
2019
Q2 | $406K | Buy |
66,700
+28,590
| +75% | +$152K | ﹤0.01% | 4514 |
|
|
2019
Q1 | $221K | Buy |
38,110
+16,731
| +78% | +$173K | ﹤0.01% | 4747 |
|
|
2018
Q4 | $288K | Sell |
21,379
-37,754
| -64% | -$637K | ﹤0.01% | 4321 |
|
|
2018
Q3 | $1.15M | Sell |
59,133
-21,090
| -26% | -$449K | ﹤0.01% | 3496 |
|
|
2018
Q2 | $2.05M | Buy |
80,223
+3,243
| +4% | +$75.6K | ﹤0.01% | 2567 |
|
|
2018
Q1 | $1.55M | Sell |
76,980
-2,480
| -3% | -$57.9K | ﹤0.01% | 2731 |
|
|
2017
Q4 | $1.6M | Sell |
79,460
-41,728
| -34% | -$821K | ﹤0.01% | 2659 |
|
|
2017
Q3 | $2.51M | Sell |
121,188
-11,993
| -9% | -$203K | ﹤0.01% | 2127 |
|
|
2017
Q2 | $1.97M | Buy |
133,181
+81,525
| +158% | +$1.36M | ﹤0.01% | 2252 |
|
|
2017
Q1 | $823K | Sell |
51,656
-89,517
| -63% | -$1.29M | ﹤0.01% | 2908 |
|
|
2016
Q4 | $1.78M | Buy |
141,173
+94,104
| +200% | +$1.75M | ﹤0.01% | 2226 |
|
|
2016
Q3 | $1.32M | Buy |
47,069
+47,059
| +470,590% | +$1.58M | ﹤0.01% | 2366 |
|
|
2016
Q2 | $0 | Sell |
10
-90
| -90% | -$2.83K | ﹤0.01% | 6783 |
|
|
2016
Q1 | $3K | Sell |
100
-172
| -63% | -$5.07K | ﹤0.01% | 5828 |
|
|
2015
Q4 | $9K | Sell |
272
-25
| -8% | -$780 | ﹤0.01% | 5443 |
|
|
2015
Q3 | $8K | Sell |
297
-3,804
| -93% | -$163K | ﹤0.01% | 5888 |
|
|
2015
Q2 | $180K | Buy |
4,101
+3,251
| +382% | +$122K | ﹤0.01% | 4212 |
|
|
2015
Q1 | $30K | Sell |
850
-90
| -10% | -$2.45K | ﹤0.01% | 5620 |
|
|
2014
Q4 | $26K | Buy |
+940
| New | +$22.8K | ﹤0.01% | 6175 |
|
Other funds holding DPLO
Barclays's DPLO Position: Q1 2020 in Review
Barclays sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 424,121 shares — an estimated $1.7M sold.
Barclays first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $2.51M in Q3 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Barclays reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Barclays sold 424,121 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.7M.
- Barclays first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Barclays's DIPLOMAT PHARMACY, INC. position peaked at $2.51M in Q3 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.